Business
The Rhythm (ASX:RHY) share price surges on cancer testing milestone
The Rhythm Biosciences Ltd (ASX: RHY) share price has opened higher on Tuesday after the successful completion of Study 6 for its ColoSTAT product. At the time of writing, the Rhythm share price is trading at $1.60, up 6.33%.
Let’s take a closer look at this announcement and what it means for the Rhythm share price.
Why the Rhythm share price opened higher on Tuesday
The Rhythm share price has surged. Climbing from a low of 3.5 cents 12-months ago to a high of $1.675 on 2 March. The company continues to hit significant milestones. In particular, for the commercialisation of its simple, affordable, and effective ColoSTAT blood test….
-
General23 hours agoChina was the big disruptor in our region. Now the US is determined to take that title
-
General23 hours agoSpaceX to invest $3 billion in Musk’s xAI startup
-
General20 hours agoWimbledon men’s final, Jannik Sinner vs Carlos Alcaraz live updates — blog, scores and stats
-
Noosa News15 hours agoAustralia Zoo reunites with the Ukrainian community